Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529655 · ClinicalTrials.gov registry record
Digital Capillary Refill for Monitoring of Sepsis
A clinical trial of Sepsis, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT04529655 is a study of Sepsis that has completed, run by Oregon Health and Science University. The registered enrollment target is 26 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04529655, a study of Sepsis, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study for monitoring of capillary refill time in sepsis
Conditions Studied
Interventions
- DEVICE Capillary Refill Assessment
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2023-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04529655
The ClinicalTrials.gov registry entry for NCT04529655 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (100% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Capillary Refill Assessment is the first listed.
NCT04529655 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT04529655 about?
NCT04529655 is a clinical study titled "Digital Capillary Refill for Monitoring of Sepsis". Observational study for monitoring of capillary refill time in sepsis
What is the current status of trial NCT04529655?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2020-08-12. Estimated completion is 2023-11-01.
What conditions does trial NCT04529655 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT04529655?
The interventions under investigation include: Capillary Refill Assessment (DEVICE).
Who is sponsoring clinical trial NCT04529655?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04529655 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.